Back to results
US 2008/0305078 A1Published application
Soluble Il-17Rc Variant and Uses Thereof
AssigneeLaboratoires Serono SA
InventorsLaurent Magnenat, Christine Power
Life of this patent
Estimating the term…
Abstract
The present invention relates to a new soluble IL-17RC variant and its therapeutic uses thereof, in particular for treating or preventing inflammatory or autoimmune disorders or neurological diseases.
Claims20
1-16. (canceled)
An isolated polypeptide comprising:
- a) a soluble IL-17RC variant polypeptide comprising SEQ ID NO:
- 1;
- b) a soluble IL-17RC variant polypeptide comprising SEQ ID NO:
- 1 fused to:
- a carrier molecule;
- peptide;
- a polypeptide;
- or a protein that promotes crossing of the blood brain barrier;
- or
- c) a soluble PEGylated IL-17RC variant polypeptide comprising SEQ ID NO:
- 1.
8 more elements
An isolated nucleic acid molecule encoding:
- a) a soluble IL-7RC variant polypeptide comprising SEQ ID NO:
- 1;
- or
- b) a soluble IL-17RC variant polypeptide comprising SEQ ID NO:
- 1 fused to:
- a carrier molecule;
- peptide;
- a polypeptide;
- or a protein that promotes crossing of the blood brain barrier.
6 more elements
Dependencies are inferred from the claim text.